Amedeo Smart

Free Medical Literature Service


 

Amedeo

Gastric Cancer

  Free Subscription

Articles published in
Br J Cancer
    November 2021
  1. CHEN K, Gu Y, Cao Y, Fang H, et al
    TIM3(+) cells in gastric cancer: clinical correlates and association with immune context.
    Br J Cancer. 2021 Nov 1. pii: 10.1038/s41416-021-01607.
    >> Share

    October 2021
  2. SHIMURA T, Kandimalla R, Okugawa Y, Ohi M, et al
    Novel evidence for m(6)A methylation regulators as prognostic biomarkers and FTO as a potential therapeutic target in gastric cancer.
    Br J Cancer. 2021 Oct 21. pii: 10.1038/s41416-021-01581.
    >> Share

  3. KOHLRUSS M, Krenauer M, Grosser B, Pfarr N, et al
    Diverse 'just-right' levels of chromosomal instability and their clinical implications in neoadjuvant treated gastric cancer.
    Br J Cancer. 2021 Oct 20. pii: 10.1038/s41416-021-01587.
    >> Share

    June 2021
  4. LEE IS, Ahn J, Kim K, Okugawa Y, et al
    A blood-based transcriptomic signature for noninvasive diagnosis of gastric cancer.
    Br J Cancer. 2021 Jun 23. pii: 10.1038/s41416-021-01461.
    >> Share

    April 2021
  5. TANAKA H, Kanda M, Miwa T, Umeda S, et al
    G-protein subunit gamma-4 expression has potential for detection, prediction and therapeutic targeting in liver metastasis of gastric cancer.
    Br J Cancer. 2021 Apr 14. pii: 10.1038/s41416-021-01366.
    >> Share

    March 2021
  6. TAKASHIMA T, Taniyama D, Sakamoto N, Yasumoto M, et al
    Schlafen 11 predicts response to platinum-based chemotherapy in gastric cancers.
    Br J Cancer. 2021 Mar 30. pii: 10.1038/s41416-021-01364.
    >> Share

  7. LI Z, Wu X, Gao X, Shan F, et al
    Development and validation of a novel staging system integrating the number and location of lymph nodes for gastric adenocarcinoma.
    Br J Cancer. 2021;124:942-950.
    >> Share

    February 2021
  8. MIWA T, Kanda M, Shimizu D, Umeda S, et al
    Hepatic metastasis of gastric cancer is associated with enhanced expression of ethanolamine kinase 2 via the p53-Bcl-2 intrinsic apoptosis pathway.
    Br J Cancer. 2021 Feb 3. pii: 10.1038/s41416-021-01271.
    >> Share

    October 2020
  9. SAITO R, Shoda K, Maruyama S, Yamamoto A, et al
    Platelets enhance malignant behaviours of gastric cancer cells via direct contacts.
    Br J Cancer. 2020 Oct 28. pii: 10.1038/s41416-020-01134.
    >> Share

  10. YAMASHITA K, Iwatsuki M, Yasuda-Yoshihara N, Morinaga T, et al
    Trastuzumab upregulates programmed death ligand-1 expression through interaction with NK cells in gastric cancer.
    Br J Cancer. 2020 Oct 26. pii: 10.1038/s41416-020-01138.
    >> Share

  11. OPENSHAW MR, Mohamed AA, Ottolini B, Fernandez-Garcia D, et al
    Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma.
    Br J Cancer. 2020;123:1271-1279.
    >> Share

    September 2020
  12. ZHAO J, Fu X, Chen H, Min L, et al
    G3BP1 interacts with YWHAZ to regulate chemoresistance and predict adjuvant chemotherapy benefit in gastric cancer.
    Br J Cancer. 2020 Sep 29. pii: 10.1038/s41416-020-01067.
    >> Share

  13. JUNTTILA A, Helminen O, Vayrynen JP, Ahtiainen M, et al
    Immunophenotype based on inflammatory cells, PD-1/PD-L1 signalling pathway and M2 macrophages predicts survival in gastric cancer.
    Br J Cancer. 2020 Sep 18. pii: 10.1038/s41416-020-01053.
    >> Share

  14. SHIMURA T, Dayde D, Wang H, Okuda Y, et al
    Novel urinary protein biomarker panel for early diagnosis of gastric cancer.
    Br J Cancer. 2020 Sep 16. pii: 10.1038/s41416-020-01063.
    >> Share

    July 2020
  15. HAGI T, Kurokawa Y, Kawabata R, Omori T, et al
    Multicentre biomarker cohort study on the efficacy of nivolumab treatment for gastric cancer.
    Br J Cancer. 2020 Jul 3. pii: 10.1038/s41416-020-0975.
    >> Share

  16. LIN JX, Yoon C, Li P, Ryeom SW, et al
    CDK5RAP3 as tumour suppressor negatively regulates self-renewal and invasion and is regulated by ERK1/2 signalling in human gastric cancer.
    Br J Cancer. 2020 Jul 1. pii: 10.1038/s41416-020-0963.
    >> Share

    June 2020
  17. KIM JH, Han KD, Lee JK, Kim HS, et al
    Correction: Association between the National Cancer Screening Programme (NSCP) for gastric cancer and oesophageal cancer mortality.
    Br J Cancer. 2020 Jun 17. pii: 10.1038/s41416-020-0946.
    >> Share

    May 2020
  18. LIN JP, Lin JX, Ma YB, Xie JW, et al
    Prognostic significance of pre- and post-operative tumour markers for patients with gastric cancer.
    Br J Cancer. 2020 May 26. pii: 10.1038/s41416-020-0901.
    >> Share

  19. NATSUME M, Shimura T, Iwasaki H, Okuda Y, et al
    Omental adipocytes promote peritoneal metastasis of gastric cancer through the CXCL2-VEGFA axis.
    Br J Cancer. 2020 May 22. pii: 10.1038/s41416-020-0898.
    >> Share

  20. KIM JH, Han KD, Lee JK, Kim HS, et al
    Association between the National Cancer Screening Programme (NSCP) for gastric cancer and oesophageal cancer mortality.
    Br J Cancer. 2020 May 13. pii: 10.1038/s41416-020-0883.
    >> Share

  21. LIU P, McMenamin UC, Johnston BT, Murchie P, et al
    Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies.
    Br J Cancer. 2020 May 5. pii: 10.1038/s41416-020-0860.
    >> Share

    April 2020
  22. GAO Y, Li J, Xi H, Cui J, et al
    Stearoyl-CoA-desaturase-1 regulates gastric cancer stem-like properties and promotes tumour metastasis via Hippo/YAP pathway.
    Br J Cancer. 2020 Apr 30. pii: 10.1038/s41416-020-0827.
    >> Share

  23. LIU HT, Ma RR, Lv BB, Zhang H, et al
    LncRNA-HNF1A-AS1 functions as a competing endogenous RNA to activate PI3K/AKT signalling pathway by sponging miR-30b-3p in gastric cancer.
    Br J Cancer. 2020 Apr 27. pii: 10.1038/s41416-020-0836.
    >> Share

    March 2020
  24. LI R, Liu H, Cao Y, Wang J, et al
    Identification and validation of an immunogenic subtype of gastric cancer with abundant intratumoural CD103(+)CD8(+) T cells conferring favourable prognosis.
    Br J Cancer. 2020 Mar 24. pii: 10.1038/s41416-020-0813.
    >> Share

  25. WU C, Ding H, Wang S, Li Y, et al
    DAXX inhibits cancer stemness and epithelial-mesenchymal transition in gastric cancer.
    Br J Cancer. 2020 Mar 23. pii: 10.1038/s41416-020-0800.
    >> Share

  26. OHMURA H, Yamaguchi K, Hanamura F, Ito M, et al
    OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody.
    Br J Cancer. 2020 Mar 23. pii: 10.1038/s41416-020-0810.
    >> Share

  27. KWAK Y, Koh J, Park Y, Hong YJ, et al
    Differential prognostic impact of CD8(+) T cells based on human leucocyte antigen I and PD-L1 expression in microsatellite-unstable gastric cancer.
    Br J Cancer. 2020 Mar 17. pii: 10.1038/s41416-020-0793.
    >> Share

    November 2019
  28. ICHIKAWA T, Okugawa Y, Toiyama Y, Tanaka K, et al
    Clinical significance and biological role of L1 cell adhesion molecule in gastric cancer.
    Br J Cancer. 2019 Nov 22. pii: 10.1038/s41416-019-0646.
    >> Share

    October 2019
  29. MASHIMA T, Iwasaki R, Kawata N, Kawakami R, et al
    In silico chemical screening identifies epidermal growth factor receptor as a therapeutic target of drug-tolerant CD44v9-positive gastric cancer cells.
    Br J Cancer. 2019 Oct 14. pii: 10.1038/s41416-019-0600.
    >> Share

    July 2019
  30. COATI I, Lotz G, Fanelli GN, Brignola S, et al
    Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases.
    Br J Cancer. 2019;121:257-263.
    >> Share

    June 2019
  31. ZHENG J, Rutegard M, Santoni G, Wallner B, et al
    Prediabetes and diabetes in relation to risk of gastric adenocarcinoma.
    Br J Cancer. 2019;120:1147-1152.
    >> Share

    March 2019
  32. KIM JH, Eom HJ, Lim G, Park S, et al
    Differential effects, on oncogenic pathway signalling, by derivatives of the HNF4 alpha inhibitor BI6015.
    Br J Cancer. 2019;120:488-498.
    >> Share

  33. FORNARO L, Vivaldi C, Parnofiello A, Ugolini C, et al
    Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer.
    Br J Cancer. 2019;120:522-526.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016